Global Gastroesophageal Reflux Disease Therapeutics Market Size is valued at USD 4.9 Bn in 2021 and is predicted to reach USD 5.9 Bn by the year 2034 at a 1.9% CAGR during the forecast period for 2025-2034.
Key Industry Insights & Findings from the Report:
Due to factors such as the low success rates associated with GERD management devices, an increase in the frequency of GERD and other gastrointestinal problems, and a rising tendency of self-medication supported by a robust product pipeline, the market for GERD treatments is expanding. Lockdowns have brought about significant lifestyle changes. The COVID-19 lockdown, remote work, sedentary lives, boredom, and anxiety directly impact people's eating patterns. There was a significant (P 0.001) rise in the number of meals, snacks, binges, and unhealthy food intake throughout the COVID-19-induced home confinement period.
Determining which people have GERD is one of the most challenging parts of calculating the condition's prevalence. Many patients with GERD-related symptoms do not seek treatment from a primary care physician (PCP). Those who do often send patients to a gastroenterologist only when symptoms stop responding to treatment after seeking PCP therapy (refractory). GERD also has a significant economic impact since the expense of long-term disease management is high because it is a chronic rather than an acute illness.
The Gastroesophageal Reflux Disease Therapeutics market is segmented on the basis of drug type. Based on drug type, the market is categorized as Antacids, H2 Receptor Blockers, Proton Pump Inhibitors (PPIs), and Pro-kinetic agents.
The bioalcohols category is expected to hold a major share in the global Gastroesophageal Reflux Disease Therapeutics market in 2021. The success and speedy relief that antacids offer are credited with the segment's dominance. Customers seeking treatment from acid reflux and heartburn spend billions of dollars on antacids, one of the most popular classes of over-the-counter pharmaceuticals available worldwide. They treat GERD, heartburn, acid indigestion, hyperacidity, and upset stomach symptoms brought on by these conditions. The segment's expansion can also be linked to the public's growing understanding of self-medication. Consumers prefer over-the-counter medications to professional medical services. Antacids have also been discovered to be helpful and have no adverse side effects in pregnancy and other diseases, further fueling the segment's rise.
Due to the rising prevalence of GERD in the local population, North America dominated the global gastroesophageal reflux disease treatment market in 2023. This trend can be due to the increasing use of GERD therapies. For instance, research that appeared in the journal GUT found that 18–28% of people in North America had GERD. Furthermore, there are more and more campaigns to raise public awareness of the problem, which is driving up demand for GERD treatments. For instance, EndoGastric Solutions, Inc. began a national campaign to support GERD awareness week in November 2022. The campaign's goal was to give GERD sufferers simple-to-follow reflux-friendly recipes.
|
Report Attribute |
Specifications |
|
Market size value in 2024 |
USD 4.9 Bn |
|
Revenue forecast in 2034 |
USD 5.9 Bn |
|
Growth rate CAGR |
CAGR of 1.9% from 2025 to 2034 |
|
Quantitative units |
Representation of revenue in US$ Million, and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report coverage |
The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends |
|
Segments covered |
Drug Type |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
|
Competitive Landscape |
AstraZeneca; Eisai Co. Ltd.; GSK plc.; Takeda Pharmaceutical Company Limited.; Ironwood Pharmaceuticals, Inc.; Johnson & Johnson Services; Inc.; SFJ Pharmaceuticals; Sebela Pharmaceuticals; Phathom Pharmaceuticals Inc.; Camber Pharmaceuticals Inc. |
|
Customization scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and available payment methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Gastroesophageal Reflux Disease Therapeutics Market Snapshot
Chapter 4. Global Gastroesophageal Reflux Disease Therapeutics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Drug Type Estimates & Trend Analysis
5.1. by Drug Type & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Drug Type:
5.2.1. Antacids
5.2.2. H2 Receptor Blockers
5.2.3. Proton Pump Inhibitors (PPIs)
5.2.4. Pro-kinetic agents
Chapter 6. Gastroesophageal Reflux Disease Therapeutics Market Segmentation 2: Regional Estimates & Trend Analysis
6.1. North America
6.1.1. North America Gastroesophageal Reflux Disease Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Drug Type, 2021-2034
6.1.2. North America Gastroesophageal Reflux Disease Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
6.2. Europe
6.2.1. Europe Gastroesophageal Reflux Disease Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Drug Type, 2021-2034
6.2.2. Europe Gastroesophageal Reflux Disease Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
6.3. Asia Pacific
6.3.1. Asia Pacific Gastroesophageal Reflux Disease Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Drug Type, 2021-2034
6.3.2. Asia Pacific Gastroesophageal Reflux Disease Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
6.4. Latin America
6.4.1. Latin America Gastroesophageal Reflux Disease Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Drug Type, 2021-2034
6.4.2. Latin America Gastroesophageal Reflux Disease Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
6.5. Middle East & Africa
6.5.1. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Drug Type, 2021-2034
6.5.2. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
Chapter 7. Competitive Landscape
7.1. Major Mergers and Acquisitions/Strategic Alliances
7.2. Company Profiles
7.2.1. AstraZeneca;
7.2.2. Aurobindo Pharma Limited
7.2.3. Cadila Pharmaceuticals Limited
7.2.4. Camber Pharmaceuticals Inc.
7.2.5. CHEPLAPHARM Arzneimittel GmbH
7.2.6. Daewoong Pharmaceutical Co., Ltd
7.2.7. Eisai Co. Ltd.
7.2.8. EndoStim, Inc.
7.2.9. GlaxoSmithKline PLC
7.2.10. Ironwood Pharmaceuticals, Inc.;
7.2.11. Jeil Pharmaceutical Co., Ltd.
7.2.12. Johnson & Johnson Services, Inc.
7.2.13. Novartis AG
7.2.14. Phathom Pharmaceuticals Inc.
7.2.15. Reckitt Benckiser Group PLC
7.2.16. Sebela Pharmaceuticals
7.2.17. SFJ Pharmaceuticals Group
7.2.18. SRS Life Sciences Pte. Ltd.
7.2.19. Sun Pharmaceutical Industries Limited
7.2.20. Takeda Pharmaceutical Company Limited.
7.2.21. Teva Pharmaceuticals Industries Limited
7.2.22. Other Prominent Players
Gastroesophageal Reflux Disease Therapeutics Market By Drug Type-
Gastroesophageal Reflux Disease Therapeutics Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
